Operating Lease, Right-of-Use Asset of Korro Bio, Inc. from 01 Jan 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Korro Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2020 to 30 Sep 2025.
  • Korro Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $23,332,000, a 2.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Korro Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23,332,000 -$686,000 -2.9% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $23,510,000 -$1,327,000 -5.3% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $23,678,000 -$2,269,000 -8.7% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $23,836,000 -$3,314,000 -12% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $24,018,000 +$22,679,000 +1694% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $24,837,000 -$2,880,000 -10% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $25,947,000 -$2,403,000 -8.5% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $27,150,000 +$25,126,000 +1241% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $1,339,000 -$28,248,000 -95% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $27,717,000 -$2,371,000 -7.9% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $28,350,000 -$2,407,000 -7.8% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $2,024,000 -$29,326,000 -94% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $29,587,000 -$2,334,000 -7.3% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $30,088,000 -$2,395,000 -7.4% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $30,757,000 -$1,830,000 -5.6% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $31,350,000 +$799,000 +2.6% 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 $31,921,000 +$30,014,000 +1574% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $32,483,000 +$30,485,000 +1526% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $32,587,000 +$30,499,000 +1461% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $30,551,000 +$29,351,000 +2446% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $1,907,000 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $1,998,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $2,088,000 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $1,200,000 01 Jan 2020 10-K 29 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.